Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

A memo from Dr Archibald McIntyre to Angus Macpherson examined further consideration the possibility that PFC might make a contribution to the supply of factor concentrates in the UK.

Published on: 30 August, 2024

Dr Lane saw PFC as being useful to England only for recovering albumin from time-expired plasma.

Published on: 30 August, 2024

Within "Notes on Feasibility Exercise Performed at Protein Fractionation Centre Liberton" it was stated instead of examining three-shift working patterns, the trial involved two shifts, each of 12 hours.

Published on: 30 August, 2024

Angus MacPherson wrote a letter to John Harley outlining that the necessary building works could be completed in approximately two and a half years.

Published on: 30 August, 2024

John Walker wrote a letter to John Cashman advising a substantial proportion of the £6-7 million identified by Angus MacPherson would be needed to rectify the shortcomings which the Medicines Inspectorate had identified in its processes.

Published on: 25 October, 2024

Within his witness statement to the Inquiry, Dr Peter Foster advised it was known to be unlikely that PFC would begin production before the end of 1973. Construction began in 1971. It continued until 1974.

Published on: 30 August, 2024

Within a Blood Products Laboratory report it was explained if PFC processed plasma to produce Factor 8 for England, then less would be needed to be spent on BPL.

Published on: 30 August, 2024

Professor Tuddenham commented on a legal opinion to the Haemophilia Society, writing "Would the provision of home produced concentrate have reduced the number of HIV infected patients? The answer here must very clearly be 'yes'".

Published on: 30 August, 2024

Professor Edward Tuddenham was asked within his oral evidence to the Inquiry if it remained his view that if self-sufficiency had been achieved, that a considerable number of cases of AIDS would have been avoided, to which he responded yes.

Published on: 30 August, 2024

Professor Michael Makris advised within his witness statement to the Inquiry that he believed that, had the UK been self-sufficient in concentrates, the number of HIV infections in haemophilia patients would have been a lot less.

Published on: 30 August, 2024

Within the minutes of a UK Haemophilia Centre directors meeting it was described by Dr Mayne as limited quantities of concentrate from Elstree and Oxford.

Published on: 30 August, 2024

Within his written statement to the Inquiry Dr Morris McClelland advised that there were capacity issues at BPL.

Published on: 30 August, 2024

Table showing annual consumption of Commercial Factor Concentrates.

Published on: 30 August, 2024

In oral evidence to the Inquiry, Dr Terence Snape apologised for not doing more, sooner.

Published on: 30 August, 2024

A statement from an investigative reporter investigating Belize's trade in plasma to the US described how a visitor to his motel room told him to take the first plane out the following morning. He left the next day.

Published on: 30 August, 2024

Cohn fractionation offered a way of separating blood into its constituent parts, and opened the possibility of using that part which was responsible for helping blood to clot without the far greater volume of blood from which it was separated.

Published on: 30 August, 2024

A lack of close oversight by the DHSS contributed to delays and expense in the redevelopment of BPL.

Published on: 30 August, 2024

Dr Maycock probably told the Chief Medical Officer that production facilities were not designed for the task nor large enough.

Published on: 30 August, 2024

A forward-looking interest was taken to updating and renewing production facilities.

Published on: 30 August, 2024

Additional major investment was needed in the UK if self-sufficiency was to be achieved.

Published on: 30 August, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2131
  • Page 2132
  • Page 2133
  • Page 2134
  • Current page 2135
  • Page 2136
  • Page 2137
  • Page 2138
  • Page 2139
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.